Conavi Medical’s reverse merger with Titan Medical, which is expected to close in July 2024, and concurrent financing are anticipated to cultivate an investor network to help fund the expansion of the Novasight Hybrid System, a breakthrough imaging platform for use by interventional cardiologists during common minimally invasive heart procedures.
Conavi Medical is an OBIO® member and alumnus of our BDSP™, CAAP® and WiHI programs, and presented at the OBIO® Investment Summit.